“I think people sometimes want permission to say there’s no answer. Sometimes, when you write that a case cannot be determined as a definitive entity (or even benign versus malignant), it makes them feel better. They can say, ‘We’re all stuck and we don’t know what it is.’ But our clinical colleagues don’t always understand that; there is always a clinician or a surgeon who thinks we can just send the case to somebody who does know. You have to teach clinicians that there isn’t an answer for everything.”
Read more from Christopher D.M. Fletcher in our upcoming interview!
Professor of Pathology at Harvard Medical School, Senior Pathologist and Vice Chair of Anatomic Pathology at Brigham and Women’s Hospital, and Chief of Onco-Pathology at the Dana-Farber Cancer Institute, Boston, USA.
